Recent News

• 02.27.2025 - LifeStance Health Fourth Quarter 2024 Earnings Call
• 02.27.2025 - LifeStance Appoints Dave Bourdon as CEO; Ken Burdick Named Executive Chairman
• 02.27.2025 - LifeStance Reports Fourth Quarter and Full Year 2024 Results
• 02.12.2025 - Role of Zurzuvae (Zuranolone) in Postpartum Depression Treatment
• 02.10.2025 - Medication Management for ADHD in Children: The Surprising Role of Sleep
• 02.10.2025 - Medication Management for ADHD in Children: The Surprising Role of Sleep
• 02.06.2025 - LifeStance to Host Fourth Quarter and Full Year 2024 Earnings Conference Call on February 27, 2025
• 02.04.2025 - Psychological Testing: Understanding Its Purpose and Benefits
• 02.04.2025 - Psychological Testing: Understanding Its Purpose and Benefits
• 01.24.2025 - Blue Monday: The Saddest Day of The Year?

Recent Filings

• 02.27.2025 - 8-K Current report
• 02.27.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 02.27.2025 - EX-99.1 EX-99.1
• 02.27.2025 - 8-K Current report
• 02.27.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.27.2025 - EX-99.1 EX-99.1
• 02.12.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors